Skip to content

Medical-device intelligence

QFG: Alternate Controller Enabled Insulin Infusion Pump

FDA product code QFG: Alternate Controller Enabled Insulin Infusion Pump. View classification details, related manufacturers, 510(k) clearances, and recall records.

FDA classification ↗

Classification details

Product code
QFG
FDA device name
Alternate Controller Enabled Insulin Infusion Pump
Device class
2
Regulation number
880.5730
Medical specialty
Clinical Chemistry
Review panel
CH

FDA definition

An alternate controller enabled insulin infusion pump (ACE insulin pump) is a device intended for the infusion of insulin into a patient. The ACE insulin pump may include basal and bolus drug delivery at set or variable rates. ACE insulin pumps are designed to reliably and securely communicate with external devices, such as automated insulin dosing systems, to allow insulin delivery commands to be received, executed, and confirmed. ACE insulin pumps are intended to be used both alone and in conjunction with digitally connected medical devices for the purpose of insulin delivery.
Explore clinical chemistry records →
A product code groups records by FDA classification. It does not establish identical intended uses, commercial availability, or comparative device safety.

Record activity in this scope

29 clearance records and 24 recall records in the covered releases, across 9 source company names and 1 product codes. Dated history runs from Sep 20, 2019 to Oct 21, 2026.

Monthly counts through October 2026
Month510(k) decisionsRecall initiations
October 202501
November 202510
December 202500
January 202612
February 202601
March 202612
April 202610
May 202602
June 202610
July 202603
August 202601
September 202611
October 202610

Product codes represented

Code and FDA device nameClearancesRecalls
QFG · Alternate Controller Enabled Insulin Infusion Pump2924

All-history totals use the covered releases; monthly counts stop at the last calendar month covered by both sources. Clearances use decision dates; recalls use initiation dates. 0 records lack the required date and are excluded from monthly counts. These are records, not product launches, market share, incidence rates, or comparative safety. Feed filters below do not change this overview.

Clearances and recall records

53 matching records
Device / recordCompany in FDA recordSourceSource date
t:slim X2 Insulin Pump with Interoperable Technology (with Tandem t:slim mobile app)Z-2621-2025 · QFGTandem Diabetes Care, Inc.RecallSep 24, 2025FDA classification date
Battery Operated infusion pumps. t:slim X2 G5, Replacement, Refurbished, REF: 1000911; t:slim X2 GS Classic, Replacement, Refurbished, REF: 10038…Z-2343-2025 · QFGTandem Diabetes Care, Inc.RecallAug 27, 2025FDA classification date
MiniMed 780G insulin pumpK251032 · QFGMedtronic Minimed, Inc.510(k)Jul 1, 2025FDA decision date
t:slim X2 Insulin Pump with Interoperable TechnologyZ-1519-2025 · QFGTandem Diabetes Care, Inc.RecallApr 11, 2025FDA classification date
Tandem Mobi Insulin Pump with Interoperable TechnologyZ-1520-2025 · QFGTandem Diabetes Care, Inc.RecallApr 11, 2025FDA classification date
twiist systemK250930 · QFGDeka Research & Development Corp.510(k)Apr 2, 2025FDA decision date
embecta Insulin Delivery SystemK234027 · QFGEmbecta Medical I, LLC510(k)Aug 30, 2024FDA decision date
Tandem Mobi Insulin Pump with interoperable technologyK241078 · QFGTandem Diabetes Care, Inc.510(k)Jul 26, 2024FDA decision date
DEKA ACE Pump SystemK241178 · QFGDeka Research and Development510(k)May 24, 2024FDA decision date
t:connect mobile app used in conjunction with t:slim X2 insulin pump with Control-IQ technologyZ-1609-2024 · QFGTandem Diabetes Care, Inc.RecallMay 6, 2024FDA classification date
Tandem Mobi insulin pump with interoperable technologyK240309 · QFGTandem Diabetes Care, Inc.510(k)Mar 21, 2024FDA decision date
DEKA ACE Pump SystemK233952 · QFGDeka Research and Development510(k)Mar 13, 2024FDA decision date
Omnipod 5 App (on compatible Android smartphones), Software Versions 1.1 - 1.2.3 (current). US: PT-000599- Omnipod 5 App Software Package (provi…Z-0591-2024 · QFGInsulet CorporationRecallJan 4, 2024FDA classification date
Inessa SystemK230545 · QFGTriple Jump Israel , Ltd.510(k)Dec 20, 2023FDA decision date
t:slim X2 Insulin Pump with Interoperable TechnologyK232380 · QFGTandem Diabetes Care, Inc.510(k)Nov 3, 2023FDA decision date
Omnipod 5 ACE PumpK231826 · QFGInsulet Corporation510(k)Oct 18, 2023FDA decision date
Tandem Mobi insulin pump with interoperable technologyK233044 · QFGTandem Diabetes Care, Inc.510(k)Oct 5, 2023FDA decision date
Omnipod 5 Automated Insulin Delivery SystemZ-2618-2023 · QFGInsulet CorporationRecallSep 20, 2023FDA classification date
Accu-Chek Solo micropump system with interoperable technologyK213134 · QFGRoche Diabetes Care GmbH510(k)Aug 10, 2023FDA decision date
DEKA ACE Pump SystemK213536 · QFGDeka Research and Development510(k)Jul 25, 2023FDA decision date
Tandem Mobi Insulin Pump with Interoperable TechnologyK223213 · QFGTandem Diabetes Care, Inc.510(k)Jul 10, 2023FDA decision date
iLet® ACE PumpK231485 · QFGBeta Bionics, Inc.510(k)Jun 21, 2023FDA decision date
iLet® ACE PumpK223846 · QFGBeta Bionics, Inc.510(k)May 19, 2023FDA decision date
Omnipod 5 Automated Insulin Delivery System Product catalog numbers: PT-000409: ASM, Omnipod 5, PDM, Programmed PT-000428: Adaptor, Charging, Noe…Z-0423-2023 · QFGInsulet CorporationRecallDec 7, 2022FDA classification date
t:slim X2 Insulin Pump with Interoperable Technology (with t:connect mobile app)K203234 · QFGTandem Diabetes Care, Inc.510(k)Feb 15, 2022FDA decision date

Manufacturers in these records

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗